LISPOLOG Trademark

Trademark Overview

On Tuesday, March 15, 2022, a trademark application was filed for LISPOLOG with the United States Patent and Trademark Office. The USPTO has given the LISPOLOG trademark a serial number of 97313192. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, November 25, 2024. This trademark is owned by Wockhardt Bio AG. The LISPOLOG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing insulin for the treatment and prevention of diabetes; inhalers filled with insulin

General Information

Serial Number97313192
Word MarkLISPOLOG
Filing DateTuesday, March 15, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, November 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations containing insulin for the treatment and prevention of diabetes; inhalers filled with insulin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWockhardt Bio AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug 6300
CH
Party NameWockhardt Bio AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Friday, March 18, 2022NEW APPLICATION ENTERED
Monday, March 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 18, 2022ASSIGNED TO EXAMINER
Friday, August 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 26, 2023SOU EXTENSION 1 FILED
Friday, May 26, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 21, 2023SOU EXTENSION 2 FILED
Tuesday, November 21, 2023SOU EXTENSION 2 GRANTED
Thursday, November 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 17, 2024SOU EXTENSION 3 FILED
Friday, May 17, 2024SOU EXTENSION 3 GRANTED
Friday, May 17, 2024SOU TEAS EXTENSION RECEIVED
Saturday, May 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2024SOU EXTENSION 4 FILED
Monday, November 25, 2024SOU EXTENSION 4 GRANTED

Related Keywords

lispolog insulin diabetes inhalers filled prevention treatment preparations containing pharmaceutical